1. Yokozawa T, Park CH, Noh JS, Roh SS. Role of oligomeric proanthocyanidins derived from an extract of persimmon fruits in the oxidative stress-related aging process. Molecules. 2014; 19(5):6707–6726.
Article
2. Lee YA, Cho EJ, Tanaka T, Yokozawa T. Inhibitory activities of proanthocyanidins from persimmon against oxidative stress and digestive enzymes related to diabetes. J Nutr Sci Vitaminol (Tokyo). 2007; 53(3):287–292.
Article
3. Zou B, Ge ZZ, Zhang Y, Du J, Xu Z, Li CM. Persimmon tannin accounts for hypolipidemic effects of persimmon through activating of AMPK and suppressing NF-κB activation and inflammatory responses in high-fat diet rats. Food Funct. 2014; 5(7):1536–1546.
Article
4. Zou B, Li CM, Chen JY, Dong XQ, Zhang Y, Du J. High molecular weight persimmon tannin is a potent hypolipidemic in high-cholesterol diet fed rats. Food Res Int. 2012; 48(2):970–977.
Article
5. Jang IC, Jo EK, Bae MS, Lee HJ, Jeon GI, Park E, Yuk HG, Ahn GH, Lee SC. Antioxidant and antigenotoxic activities of different parts of persimmon (Diospyros kaki cv. Fuyu) fruit. J Med Plant Res. 2010; 4(2):155–160.
6. Matsumoto K, Yokoyama S, Gato N. Hypolipidemic effect of young persimmon fruit in C57BL/6.KOR-ApoEshl mice. Biosci Biotechnol Biochem. 2008; 72(10):2651–2659.
7. Matsumoto K, Yokoyama S, Gato N. Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice. Phytother Res. 2010; 24(2):205–210.
8. Ahn Y, Gebereamanuel MR, Oh EK, Kwon O. Inhibitory effects of persimmon (Diospyros kaki Thumb.) against diet-induced hypertriglyceridemia/hypercholesterolemia in rats. J Nutr Health. 2017; 50(3):225–235.
9. Del Bubba M, Giordani E, Pippucci L, Cincinelli A, Checchini L, Galvan P. Changes in tannins, ascorbic acid and sugar content in astringent persimmons during on-tree growth and ripening and in response to different postharvest treatments. J Food Compos Anal. 2009; 22(7-8):668–677.
Article
10. Association of Official Analytical Chemists. Official methods of analysis. 15th edition. Arlington (VA): Association of Official Analytical Chemists.
11. Adams MA, Bobik A, Korner PI. Differential development of vascular and cardiac hypertrophy in genetic hypertension. Relation to sympathetic function. Hypertension. 1989; 14(2):191–202.
Article
12. Karaman S, Toker ÖS, Yüksel F, Çam M, Kayacier A, Dogan M. Physicochemical, bioactive, and sensory properties of persimmon-based ice cream: technique for order preference by similarity to ideal solution to determine optimum concentration. J Dairy Sci. 2014; 97(1):97–110.
Article
13. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr. 2006; 136(10):2588–2593.
Article
14. Zhao D, Zhou C, Sheng Y, Liang G, Tao J. Molecular cloning and expression of phytoene synthase, lycopene beta-cyclase, and beta-carotene hydroxylase genes in persimmon (Diospyros kaki L.) fruits. Plant Mol Biol Report. 2011; 29(2):345–351.
15. Santos AD, Fonseca FA, Dutra LM, Santos MF, Menezes LR, Campos FR, Nagata N, Ayub R, Barison A. 1H HR-MAS NMR-based metabolomics study of different persimmon cultivars (Diospyros kaki) during fruit development. Food Chem. 2018; 239:511–519.
16. Bitou N, Ninomiya M, Tsujita T, Okuda H. Screening of lipase inhibitors from marine algae. Lipids. 1999; 34(5):441–445.
Article
17. Latha RC, Daisy P. Insulin-secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin-induced diabetic rats. Chem Biol Interact. 2011; 189(1-2):112–118.
Article
18. Hsu CL, Yen GC. Effect of gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr. 2007; 98(4):727–735.
Article
19. Ngamukote S, Mäkynen K, Thilawech T, Adisakwattana S. Cholesterol-lowering activity of the major polyphenols in grape seed. Molecules. 2011; 16(6):5054–5061.
Article
20. Roth BD, Blankley CJ, Hoefle ML, Holmes A, Roark WH, Trivedi BK, Essenburg AD, Kieft KA, Krause BR, Stanfield RL. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agents. J Med Chem. 1992; 35(9):1609–1617.
Article
21. Seo JB, Moon HM, Kim WS, Lee YS, Jeong HW, Yoo EJ, Ham J, Kang H, Park MG, Steffensen KR, Stulnig TM, Gustafsson JA, Park SD, Kim JB. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor γ expression. Mol Cell Biol. 2004; 24(8):3430–3444.
Article
22. Chen W, Yang CC, Sheu HM, Seltmann H, Zouboulis CC. Expression of peroxisome proliferator-activated receptor and CCAAT/enhancer binding protein transcription factors in cultured human sebocytes. J Invest Dermatol. 2003; 121(3):441–447.
Article
23. Lee SM, Han HW, Kim Y. JNK-mediated SREBP-2 processing by genistein up-regulates LDLR expression in HepG2 cells. Nutr Food Sci. 2014; 4:308.
24. Russell DW, Setchell KD. Bile acid biosynthesis. Biochemistry. 1992; 31(20):4737–4749.
Article
25. Hashimoto K, Cohen RN, Yamada M, Markan KR, Monden T, Satoh T, Mori M, Wondisford FE. Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model. J Biol Chem. 2006; 281(1):295–302.
Article
26. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med. 2006; 354(12):1264–1272.
27. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011; 13(4):376–388.
Article